Innovations in CAR T-Cell Therapy for Multiple Myeloma

Innovations in CAR T-Cell Therapy for Multipl...

AMERICAN SOCIETY OF CLINICAL ONCOLOGY (ASCO)AMERICAN SOCIETY OF CLINICAL ONCOLOGY (ASCO)

‏التالي

Updates in Bladder Cancer: From Intravesical Breakthroughs to Managing Toxicities

Dr. Monty Pal and Dr. Petros Grivas discuss the rapidly evolving management of bladder cancer, including key updates in non-muscle-invasive disease, the integration of novel therapies in the advanced setting, and practical strategies for managing toxicities in clinical practice. ...  عرض المزيد

 . 23 دقيقة و1 ثانية
How Do We Translate ASCO26 Research Into Practice in Latin America?

In part two of our miniseries on the global translation gap in oncology, host Dr. Monty Pal and Dr. Regina Barragán-Carrillo explore how ASCO26 Plenary breakthroughs can be adapted to clinical practice in Latin America. Together, they address real-world implementation challenges ...  عرض المزيد

 . 21 دقيقة و36 ثانية

‏حلقات موصى بها

S2 Episode 3: When Is the Best Time to Use CAR T-Cell Therapy in Multiple Myeloma?
Medscape InDiscussion: Multiple Myeloma

Joseph Mikhael, MD, and Krina K. Patel, MD, MSc, discuss considerations for CAR T-Cell therapy in multiple myeloma, including age, access, and bridging therapy. Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/viewarticle/1002715. ...  عرض المزيد

 . 24 دقيقة و38 ثانية
Jason Westin, MD, MS, FACP - Rising to the Occasion: Improving Outcomes in Leukemia, Lymphoma, and Multiple Myeloma With CAR T-Cell Therapy in Community Practice
PeerView Heart, Lung & Blood CME/CNE/CPE Audio Podcast

Go online to PeerView.com/NMF860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Chimeric antigen receptor T-cell (CAR T) therapy, a validated novel therapeutic strategy in leukemic and lymphoid malignancies, continues to provid ...  عرض المزيد

 . 1 ساعة و 30 دقيقة متبقية
CAR-T Treatment in Myeloma: State of the Art
EHA Unplugged

Join us for another episode of EHA Unplugged. We have Prof. Herman Einsele here talking about the current landscapes of CAR-T therapy in myeloma, results achievable today, and the future perspectives for these patients.This podcast episode is part of our FREE course on CAR-T Upda ...  عرض المزيد

 . 7 دقيقة و1 ثانية
CAR T-cell Therapy in AML: State of the Art
EHA Unplugged

Tune in to our podcast for an in-depth discussion on immunotherapeutic strategies for Acute Myeloid Leukemia (AML). In this episode, we feature Dr Sarah Tettamanti, a senior scientist at the Fondazione Tettamanti Research Centre in Italy, who shares her expertise on CAR T-cell th ...  عرض المزيد

 . 15 دقيقة و1 ثانية